论文部分内容阅读
糖尿病肾病(DN)是最常见的糖尿病微血管并发症,也是糖尿病患者重要死因之一。近年来,血管活性多肽对DN发生、发展的影响已被人们所重视,并已试图应用相应的拮抗剂阻断其发生和发展。本文研究降钙素基因相关肽(CGRP)、一氧化氮(NO)在DN发展过程中的作用及血管紧张素Ⅱ受体拮抗剂
Diabetic nephropathy (DN) is the most common diabetic microvascular complication and one of the major causes of death in people with diabetes. In recent years, the impact of vasoactive peptides on the occurrence and development of DN has been taken seriously, and it has been attempted to use the corresponding antagonist to block its occurrence and development. This article studies the effects of calcitonin gene related peptide (CGRP) and nitric oxide (NO) on the development of DN and the effects of angiotensin Ⅱ receptor antagonist